Your browser doesn't support javascript.
loading
Chitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment.
Sharifi-Rad, Javad; Quispe, Cristina; Butnariu, Monica; Rotariu, Lia Sanda; Sytar, Oksana; Sestito, Simona; Rapposelli, Simona; Akram, Muhammad; Iqbal, Mehwish; Krishna, Akash; Kumar, Nanjangud Venkatesh Anil; Braga, Susana S; Cardoso, Susana M; Jafernik, Karolina; Ekiert, Halina; Cruz-Martins, Natália; Szopa, Agnieszka; Villagran, Marcelo; Mardones, Lorena; Martorell, Miquel; Docea, Anca Oana; Calina, Daniela.
Afiliación
  • Sharifi-Rad J; Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. javad.sharifirad@gmail.com.
  • Quispe C; Facultad de Medicina, Universidad del Azuay, Cuenca, Ecuador. javad.sharifirad@gmail.com.
  • Butnariu M; Facultad de Ciencias de La Salud, Universidad Arturo Prat, Avda. Arturo Prat 2120, 1110939, Iquique, Chile.
  • Rotariu LS; Banat's University of Agricultural Sciences and Veterinary Medicine "King Michael I of Romania" From Timisoara, Calea Aradului 119, 300645, Timis, Romania. monicabutnariu@yahoo.com.
  • Sytar O; Banat's University of Agricultural Sciences and Veterinary Medicine "King Michael I of Romania" From Timisoara, Calea Aradului 119, 300645, Timis, Romania.
  • Sestito S; Department of Plant Biology Department, Institute of Biology, Taras Shevchenko National University of Kyiv, Kyiv, 01033, Ukraine.
  • Rapposelli S; Department of Plant Physiology, Slovak University of Agriculture, Nitra, 94976, Slovak Republic.
  • Akram M; Department of Pharmacy, University of Pisa, Via bonanno 6, 56126, Pisa, Italy.
  • Iqbal M; Department of Plant Physiology, Slovak University of Agriculture, Nitra, 94976, Slovak Republic.
  • Krishna A; Department of Pharmacy, University of Pisa, Via bonanno 6, 56126, Pisa, Italy.
  • Kumar NVA; Department of Eastern Medicine and Surgery, Directorate of Medical Sciences, GC University Faisalabad, Faisalabad, Pakistan.
  • Braga SS; Institute of Health Management, Dow University of Health Sciences, Karachi, Pakistan.
  • Cardoso SM; Department of Chemistry, Manipal Institute of Technology, Manipal Academy of Higher Education, Manipal, 576104, India.
  • Jafernik K; Department of Chemistry, Manipal Institute of Technology, Manipal Academy of Higher Education, Manipal, 576104, India.
  • Ekiert H; LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, 3810-193, Aveiro, Portugal.
  • Cruz-Martins N; LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, 3810-193, Aveiro, Portugal.
  • Szopa A; Department of Pharmaceutical Botany, Medical College, Jagiellonian University, Medyczna 9, 30-688, Kraków, Poland.
  • Villagran M; Department of Pharmaceutical Botany, Medical College, Jagiellonian University, Medyczna 9, 30-688, Kraków, Poland.
  • Mardones L; Faculty of Medicine, University of Porto, Porto, Portugal. ncmartins@med.up.pt.
  • Martorell M; Institute for Research and Innovation in Health (i3S), University of Porto, Porto, Portugal. ncmartins@med.up.pt.
  • Docea AO; Institute of Research and Advanced Training in Health Sciences and Technologies, Cooperativa de Ensino Superior Politécnico e Universitário (CESPU), 4585-116, Gandra, Portugal. ncmartins@med.up.pt.
  • Calina D; Department of Pharmaceutical Botany, Medical College, Jagiellonian University, Medyczna 9, 30-688, Kraków, Poland. a.szopa@uj.edu.pl.
Cancer Cell Int ; 21(1): 318, 2021 Jun 24.
Article en En | MEDLINE | ID: mdl-34167552
ABSTRACT
The study describes the current state of knowledge on nanotechnology and its utilization in medicine. The focus in this manuscript was on the properties, usage safety, and potentially valuable applications of chitosan-based nanomaterials. Chitosan nanoparticles have high importance in nanomedicine, biomedical engineering, discovery and development of new drugs. The manuscript reviewed the new studies regarding the use of chitosan-based nanoparticles for creating new release systems with improved bioavailability, increased specificity and sensitivity, and reduced pharmacological toxicity of drugs. Nowadays, effective cancer treatment is a global problem, and recent advances in nanomedicine are of great importance. Special attention was put on the application of chitosan nanoparticles in developing new system for anticancer drug delivery. Pre-clinical and clinical studies support the use of chitosan-based nanoparticles in nanomedicine. This manuscript overviews the last progresses regarding the utilization, stability, and bioavailability of drug nanoencapsulation with chitosan and their safety.
Palabras clave